[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
[ Tue, Jun 04th 2024 ]: WOPRAI
Salveen Richter Maintained (AGIO) at Hold with Increased Target to $53 on, Jun 4th, 2024
- 🞛 This publication is a summary or evaluation of another publication
Salveen Richter of Goldman Sachs, Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Hold with Increased Target from $33 to $53 on, Jun 4th, 2024.
Salveen has made no other calls on AGIO in the last 4 months.
There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, 1 agrees with Salveen's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tessa Romero of "JP Morgan" Maintained at Hold with Decreased Target to $30 on, Friday, February 23rd, 2024
This is the rating of the analyst that currently disagrees with Salveen
- Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy on, Tuesday, April 9th, 2024